Ventas (NYSE:VTR) Price Target Raised to $90.00

Ventas (NYSE:VTR) had its price target increased by equities research analysts at KeyCorp from $85.00 to $90.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the real estate investment trust’s stock. KeyCorp’s price target points to a potential upside of 8.83% from the company’s previous close.

A number of other research analysts have also recently issued reports on VTR. Citigroup boosted their price objective on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a report on Tuesday, November 11th. The Goldman Sachs Group reissued a “buy” rating and issued a $100.00 price target on shares of Ventas in a report on Monday. Cantor Fitzgerald restated an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research report on Monday. UBS Group reiterated a “neutral” rating and set a $85.00 target price on shares of Ventas in a report on Monday. Finally, Wells Fargo & Company boosted their target price on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.06.

Ventas Stock Up 0.2%

Shares of Ventas stock opened at $82.70 on Tuesday. The business has a fifty day simple moving average of $78.17 and a 200 day simple moving average of $73.39. The stock has a market cap of $38.85 billion, a PE ratio of 153.15, a price-to-earnings-growth ratio of 2.03 and a beta of 0.77. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas has a 12 month low of $58.72 and a 12 month high of $84.10.

Ventas (NYSE:VTR) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The company had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.Ventas’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Research analysts predict that Ventas will post 3.4 EPS for the current year.

Insider Activity

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Peter J. Bulgarelli sold 2,229 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $80.08, for a total value of $178,498.32. Following the transaction, the chief executive officer directly owned 106,488 shares of the company’s stock, valued at approximately $8,527,559.04. This trade represents a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 130,459 shares of company stock worth $10,152,803 over the last three months. Corporate insiders own 1.00% of the company’s stock.

Institutional Trading of Ventas

A number of institutional investors have recently made changes to their positions in the business. Bridgewater Advisors Inc. raised its holdings in Ventas by 2.0% in the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after acquiring an additional 133 shares during the last quarter. Arbor Capital Management Inc. ADV raised its stake in shares of Ventas by 0.6% in the third quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock worth $1,520,000 after buying an additional 137 shares during the period. True Wealth Design LLC raised its position in shares of Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 138 shares during the period. Cigna Investments Inc. New raised its stake in Ventas by 3.3% during the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after purchasing an additional 142 shares during the period. Finally, Foundations Investment Advisors LLC boosted its position in shares of Ventas by 3.3% during the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after acquiring an additional 144 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.